Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Exchange Rate Effect of -$157000.0 for Q1 2026, down 117.29% year-over-year from $908000.0 in Q1 2025, and down 149.21% quarter-over-quarter from -$63000.0 in Q4 2025.
Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Exchange Rate Effect for 4 consecutive years, with -$157000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 117.29% year-over-year to -$157000.0; the TTM figure through Mar 2026 stood at $789000.0 (up 5.91% YoY), while the FY2025 annual figure was $1.9 million, up 895.71% from the prior year.
- Exchange Rate Effect eased to -$157000.0 in Q1 2026 per MREO's latest filing, from -$63000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.7 million in Q4 2023 and bottomed at -$1.3 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $329384.6 across 4 years, with a median of -$63000.0 in 2025.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect sank 174.91% — and 2025, when it jumped 1433.64%.
- Mereo BioPharma's Exchange Rate Effect stood at $1.7 million in 2023, then tumbled by 174.91% to -$1.3 million in 2024, then jumped by 95.0% to -$63000.0 in 2025, then plunged by 149.21% to -$157000.0 in 2026.
- Business Quant data shows MREO's Exchange Rate Effect at -$157000.0 in Q1 2026, -$63000.0 in Q4 2025, and -$418000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Mereo BioPharma | 47.30 Mn | 47.30 Mn | - | -62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -62,000.00 |
| Jun 30, 2026 | -62,000.00 |
| Mar 31, 2026 | -157,000.00 |
| Mar 31, 2026 | -157,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Sep 30, 2025 | -418,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 908,000.00 |
| Mar 31, 2025 | 908,000.00 |
| Dec 31, 2024 | -1.26 Mn |
| Dec 31, 2024 | -1.26 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | -107,000.00 |
| Jun 30, 2024 | -107,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |